Manuel Perrier1, Mikaël Sébag. 1. Ophthalmology Department, Centre Hospitalier Université de Montréal-Pavillon Notre-Dame, Montréal, Québec, Canada. perrier.manuel@sympatico.ca
Abstract
PURPOSE: To evaluate patient outcome following epiretinal membrane surgery using trypan blue to facilitate visualization and delamination. DESIGN: A retrospective noncomparative review of 23 patients. METHOD: Patients underwent a three-port pars plana vitrectomy with delamination using trypan blue 0.06%. RESULTS: The median preoperative visual acuity was 20/100. The median postoperative visual acuity was 20/60. Seventeen patients (74%) improved their visual acuity by at least 2 chart lines. No adverse reaction related to trypan blue was observed up to 1 year postoperatively. CONCLUSIONS: Trypan blue staining of the epiretinal membrane facilitated visualization and delamination without any signs of toxicity.
PURPOSE: To evaluate patient outcome following epiretinal membrane surgery using trypan blue to facilitate visualization and delamination. DESIGN: A retrospective noncomparative review of 23 patients. METHOD:Patients underwent a three-port pars plana vitrectomy with delamination using trypan blue 0.06%. RESULTS: The median preoperative visual acuity was 20/100. The median postoperative visual acuity was 20/60. Seventeen patients (74%) improved their visual acuity by at least 2 chart lines. No adverse reaction related to trypan blue was observed up to 1 year postoperatively. CONCLUSIONS:Trypan blue staining of the epiretinal membrane facilitated visualization and delamination without any signs of toxicity.
Authors: Emmerson Badaró; Milton Moraes-Filho; Mauricio Maia; Fernando M Penha; Eduardo Amorim Novais; Rodrigo A Souza-Lima; Flavio Hirai; Carsten H Meyer; Michel Eid Farah; Eduardo B Rodrigues Journal: J Ophthalmic Vis Res Date: 2014-04